L
Long Beach Clinical Trials Services, Inc | Long Beach, CA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Atogepant
Tolperisone
PF-06882961
PF-06651600
Maridebart Cafraglutide
PF-06700841
Permethrin
Erenumab
Centanafadine
VX-548
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
2 of 17 total trials
To evaluate long-term safety exposure
Active, not recruiting
Attention Deficit/Hyperactivity Disorder
Drug: Centanafadine Hydrochloride
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Active, not recruiting
Obesity
Drug: Placebo
Drug: Maridebart Cafraglutide
Trial sponsors
N
A
S
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems